SECreport

Form 4 Global Blood Therapeutic For: Nov 14 Filed by: Lehrer-Graiwer Joshua

Global Blood Therapeutics, Inc.  (GBT) 
NASDAQ:AMEX Investor Relations: ir.globalbloodtx.com